⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22107548 | 0.91 | CHRNA7 (0.41) | — | |
| SCHEMBL21557327 | 0.87 | KDM4E (0.39) | — | |
| SCHEMBL4458414 | 0.86 | CHRNA7 (0.38) | — | |
| SCHEMBL21061429 | 0.86 | CHRNA7 (0.38) | — | |
| SCHEMBL12065336 | 0.84 | CHRNA7 (0.37) | — | |
| SCHEMBL20354937 | 0.84 | CHRNA7 (0.42) | — | |
| SCHEMBL20355018 | 0.82 | CHRNA7 (0.41) | — | |
| SCHEMBL24993844 | 0.81 | SIGMAR1 (0.42) | — | |
| SCHEMBL21124937 | 0.81 | CHRNA7 (0.38) | — | |
| SCHEMBL24245112 | 0.80 | CHRNA7 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024127363-A1 | TYK2 PSEUDOKINASE LIGANDS AND USES THEREOF | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2024-06-20 | — | — | WO | disclosed |
| WO-2020156311-A1 | PYRIDAZINE DERIVATIVE INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF | 江苏豪森药业集团有限公司 | 2020-08-06 | — | — | WO | disclosed |
| WO-2020034987-A1 | PRODRUG CONTAINING GLUCURONIDE DERIVATIVE OF JAK INHIBITOR, PREPARATION METHOD THEREFOR, AND USES THEREOF | 江苏豪森药业集团有限公司 | 2020-02-20 | — | — | WO | disclosed |
| WO-2020020385-A1 | TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION | 上海翰森生物医药科技有限公司 | 2020-01-30 | — | — | WO | disclosed |
| WO-2019228341-A1 | INHIBITOR CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 江苏豪森药业集团有限公司 (CN) | 2019-12-05 | — | — | WO | disclosed |